PFT Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

PFT Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

PFT (Pulmonary Function Test) Devices Market Overview

The Pulmonary Function Test (PFT) devices market is essential for diagnosing and monitoring respiratory diseases, particularly conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary disorders. These devices are critical in healthcare environments including hospitals, diagnostic laboratories, and home care settings. The market includes several device types, including spirometers, peak flow meters, gas exchange testing tools, and lung volume measurement systems, which each play unique roles in assessing and managing respiratory health.

Market Size

The PFT devices market is experiencing significant growth due to the rising prevalence of respiratory diseases, an aging population, and increasing investments in healthcare diagnostics. The market is expected to grow at a compound annual growth rate (CAGR) ranging from 5% to 7% during the forecast period, driven by technological advancements in PFT devices, alongside growing awareness and demand for early detection and management of respiratory conditions.

Market Share & Trends Analysis

By Application

The market for PFT devices is segmented by application, including hospitals, diagnostic laboratories, home care settings, and others. The growth rates for each segment are as follows:

• Hospitals: Hospitals are projected to hold the largest market share, with a CAGR of 6% to 8%. The increasing use of PFT devices for respiratory disease diagnosis and management is a key factor driving this growth.
• Diagnostic Laboratories: This segment is expected to grow at a CAGR of 5% to 7%, with an increasing number of specialized laboratories offering PFT services.
• Home Care Settings: Home care settings are expected to experience the highest growth, with a CAGR of 7% to 9%, as more patients opt for at-home respiratory health monitoring.
• Others: This category, which includes diverse medical and research settings, is expected to grow at a CAGR of 4% to 6%.

By Product Type

The PFT devices market is divided into various product categories, with the following growth trends:

• Spirometers: Spirometers are projected to dominate the market, with a CAGR of 6% to 8%, as they remain one of the most common diagnostic tools for lung function assessment.
• Peak Flow Meters: This product type is expected to experience moderate growth, with a CAGR of 4% to 6%, driven by their use in managing asthma and other respiratory diseases.
• Gas Exchange Testing: The gas exchange testing segment is forecast to grow at a CAGR of 5% to 7%, fueled by advancements in respiratory technology and heightened awareness of the importance of gas exchange in respiratory health.
• Lung Volume Measurement: This segment is expected to grow at a rate of 5% to 7%, as these devices are key in diagnosing conditions like emphysema and pulmonary fibrosis.
• Others: Other PFT devices, including new innovations in diagnostic tools, are expected to grow at a moderate rate, with a CAGR of 4% to 6%.

By Key Players

The PFT devices market is competitive, with numerous established players, including:

• MGC Diagnostics Corporation
• CareFusion Corporation
• COSMED Srl
• NDD Medical Technologies, Inc.
• Schiller AG
• Vyaire Medical, Inc.
• Medisoft SA
• Fukuda Sangyo Co., Ltd.
• Jones Medical Instrument Company
• Vitalograph Ltd.
• Smiths Medical
• Philips Healthcare
• General Electric Company
• ResMed Inc.
• Hill-Rom Holdings, Inc.
• SpiroTech Medical Inc.
• Thor Laboratories
• Geratherm Respiratory GmbH
• Labtech Ltd.
• Medical International Research

By Region

The PFT devices market is expected to grow across various regions:

• North America: The North American market is forecast to grow at a CAGR of 6% to 8%, due to high levels of respiratory disease prevalence and strong healthcare infrastructure.
• Europe: Europe is projected to grow at a CAGR of 5% to 7%, supported by an aging population and increasing demand for respiratory diagnostics.
• Asia-Pacific: The Asia-Pacific region is expected to experience the fastest growth, with a CAGR of 7% to 9%, driven by improving healthcare access and increasing awareness of respiratory conditions.
• Rest of the World: The Rest of the World, including Latin America and the Middle East, is expected to see moderate growth, with a CAGR of 4% to 6%, as respiratory care demand rises with improved healthcare access.

Segment Forecasts (2025-2030)

Growth in Key Segments

• Hospitals: The hospital segment is expected to continue being the largest, with a CAGR of 6% to 8%, as PFT devices are increasingly adopted in hospital settings for diagnosing and managing respiratory diseases.
• Diagnostic Laboratories: The diagnostic laboratory segment is projected to see steady growth at a CAGR of 5% to 7%, driven by the growing demand for accurate pulmonary diagnostics.
• Home Care Settings: Home care is expected to experience rapid growth, with a projected CAGR of 7% to 9%, as more patients prefer monitoring respiratory health from home.